The natural history of nonalcoholic fatty liver: a follow-up study
- PMID: 7489979
The natural history of nonalcoholic fatty liver: a follow-up study
Abstract
Nonalcohol-induced fatty liver is widely believed to be a benign condition with little or no risk of disease progression. There have been occasional reports of progression to cirrhosis but none in the absence of preexisting fibrosis on the index biopsy specimen even when co-existing hepatitis was present (steatohepatitis). From our histological database (1978 to 1985), we identified 161 patients with fatty liver seen at our institution and traced the case notes of 156. One hundred five patients were initially excluded as having an alcohol-induced cause, and the remaining 51 either were seen in the clinic (37) or had died, in which cases copies of their death certificates were obtained (14). A further 7 patients were excluded after clinic attendance gave evidence of alcohol excess and another 4 after review of their initial biopsy showed the presence of fibrosis or steatohepatitis. The apparent cause of the steatosis in the 40 included patients with strictly nonalcohol-induced pure fatty liver was obesity in 12, diabetes in 4 (1 obese patient), and cachexia associated with extrahepatic malignancy in 6. Four of the remaining 19 had serological evidence of an autoimmune disorder, but none of these had any clinical or histological features of autoimmune liver disease. Nine patients had evidence of hyperlipidemia, 3 of whom were also obese. At a median follow-up of 11 years (7 to 16), 12 of 26 living patients had abnormal results of liver blood tests and had repeat liver biopsies performed. None had progressed to steatohepatitis or cirrhosis; 1 obese patient had developed mild fibrosis 9.8 years after her index biopsy.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.Am J Gastroenterol. 2003 Sep;98(9):2042-7. doi: 10.1111/j.1572-0241.2003.07659.x. Am J Gastroenterol. 2003. PMID: 14499785
-
Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.Hepatology. 2004 Oct;40(4):820-6. doi: 10.1002/hep.20410. Hepatology. 2004. PMID: 15382171
-
The clinical associations with hepatic steatosis: a retrospective study.N Z Med J. 1992 Feb 26;105(928):57-8. N Z Med J. 1992. PMID: 1542474
-
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.Clin Liver Dis. 2004 Aug;8(3):521-33, viii. doi: 10.1016/j.cld.2004.04.004. Clin Liver Dis. 2004. PMID: 15331061 Review.
-
Nonalcoholic fatty liver disease: is all the fat bad?Intern Med J. 2004 Apr;34(4):187-91. doi: 10.1111/j.1444-0903.2004.00574.x. Intern Med J. 2004. PMID: 15086699 Review.
Cited by
-
Pathophysiology of NASH: perspectives for a targeted treatment.Curr Pharm Des. 2013;19(29):5250-69. doi: 10.2174/13816128113199990344. Curr Pharm Des. 2013. PMID: 23394092 Free PMC article.
-
Inhibition of LXRα/SREBP-1c-Mediated Hepatic Steatosis by Jiang-Zhi Granule.Evid Based Complement Alternat Med. 2013;2013:584634. doi: 10.1155/2013/584634. Epub 2013 May 16. Evid Based Complement Alternat Med. 2013. PMID: 23762146 Free PMC article.
-
Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease.J Gastroenterol. 2013 Dec;48(12):1392-400. doi: 10.1007/s00535-013-0766-5. Epub 2013 Mar 13. J Gastroenterol. 2013. PMID: 23478936 Free PMC article.
-
Characteristics of NAFLD Based on Hypopituitarism.Can J Gastroenterol Hepatol. 2020 Oct 10;2020:8814435. doi: 10.1155/2020/8814435. eCollection 2020. Can J Gastroenterol Hepatol. 2020. PMID: 33102399 Free PMC article.
-
Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease.Hepatology. 2010 Jan;51(1):111-20. doi: 10.1002/hep.23271. Hepatology. 2010. PMID: 19885878 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources